OLB The OLB rises 23 percent after Q4 2025 earnings outpace consensus analyst EPS estimates Enliven Therapeutics ELVN Stock Industry Opportunities 082 20260427 Is PennantPark PNNT stock worth initiating exposure Q1 2026 Profit Disappoints